Inventor
PRIESTLEY ELDON SCOTT
US24 patents
⚠️ This page may combine multiple inventors who share the name “PRIESTLEY ELDON SCOTT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
20 patentsUS6803374B2Oct 12, 2004
Compounds useful for treating hepatitis C virus
BRISTOL MYERS SQUIBB CO41 citations92
US9688695B2Jun 27, 2017
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
BRISTOL MYERS SQUIBB CO11 citations90
US10822343B2Nov 3, 2020
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
BRISTOL MYERS SQUIBB CO4 citations83
US10428077B2Oct 1, 2019
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
BRISTOL MYERS SQUIBB CO8 citations83
US10047103B2Aug 14, 2018
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
BRISTOL MYERS SQUIBB CO11 citations83
US9518064B2Dec 13, 2016
Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
BRISTOL MYERS SQUIBB CO5 citations72
US9174974B2Nov 3, 2015
Macrocyclic factor VIIa inhibitors
BRISTOL MYERS SQUIBB CO5 citations71
US7456195B2Nov 25, 2008
Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
BRISTOL MYERS SQUIBB CO6 citations62
US12084452B2Sep 10, 2024
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
BRISTOL MYERS SQUIBB CO0 citations60
USRE49700EOct 17, 2023
Substituted nitrogen containing compounds
BRISTOL MYERS SQUIBB CO0 citations60
US10501449B2Dec 10, 2019
Substituted nitrogen containing compounds
BRISTOL MYERS SQUIBB CO1 citations60
US7592331B2Sep 22, 2009
Macrocyclic factor VIIa inhibitors useful as anticoagulants
BRISTOL MYERS SQUIBB CO5 citations60
US12528827B2Jan 20, 2026
Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations59
US11932658B2Mar 19, 2024
Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors
BRISTOL MYERS SQUIBB CO1 citations59
US10730868B2Aug 4, 2020
Bicyclic heteroaryl substituted compounds
BRISTOL MYERS SQUIBB CO1 citations59
US12060347B2Aug 13, 2024
Bicyclic heteroaryl substituted compounds
BRISTOL MYERS SQUIBB CO0 citations47
US7622585B2Nov 24, 2009
Phenylglycinamide derivatives useful as anticoagulants
BRISTOL MYERS SQUIBB CO0 citations41
US10815224B2Oct 27, 2020
Monocyclic heteroaryl substituted compounds
BRISTOL MYERS SQUIBB CO0 citations39
US10723723B2Jul 28, 2020
Substituted bicycle heterocyclic derivatives useful as ROMK channel inhibitors
BRISTOL MYERS SQUIBB CO0 citations39
US8039506B2Oct 18, 2011
Bicyclic lactam factor VIIa inhibitors useful as anticoagulants
BRISTOL MYERS SQUIBB CO0 citations38